lobbying_activities: 3186413

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3186413 aa04074b-44b0-484c-824f-c72343cc5ef2 Q2 INLET STRATEGIES 401106604 COHERUS BIOSCIENCES, INC 2024 second_quarter MMM Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 45000   0 0 2024-07-06T19:49:18-04:00